6K7-24788-36647

2 vaccinations 6 coded responses 17 check-ins 6 free-text entries 2 call cases

Sex: Female
Age at first dose: 56-60
ZIP prefix: 220 / VA
Registered: 2020-12-18

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-18
Registered in v-safe
2020-12-18
Dose 1 — Pfizer-BioNTech
2020-12-18
Health check-in — day 0, dose 1
Feeling: Good · None

Adult check-in
2020-12-19
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-20
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-21
Survey response — days 1–6 daily, dose 1
MedDRA: Dyspnoea exertional, Rash, Rash morbilliform — Feeling: Good · Fatigue or tiredness, Rash, not including the immediate area around the injection site

Free text: New morbilliform rash on upper extremities, chest and abdomen. Mild shortness of breath when running

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-22
Survey response — days 1–6 daily, dose 1
MedDRA: Cough, Dyspnoea, Herpes simplex, Office visit, Rash, Rash morbilliform, Respiratory symptom, SARS-CoV-2 test negative — Feeling: Good · Fatigue or tiredness, Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Systemic reaction (other): Morbilliform rash upper arms, chest and abdomen improved; new mild cough and intermittent breathlessness; new oral herpes lesion (first time in over a year and most severe in a decade · Healthcare visit (other): Went to Covid screening area based on occupational health recommendation due to new respiratory symptoms. Covid test negative.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-22
Report sent to call center — days 1–6 daily, dose 1
Get care from a doctor or other healthcare professional

1 call case(s)
2020-12-23
Survey response — days 1–6 daily, dose 1
MedDRA: Cough, Dyspnoea — Feeling: Good · Fatigue or tiredness

Free text: Still occasionally breathless and with occasional cough

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-25
Survey response — day 7, dose 1
MedDRA: Oral herpes — Feeling: Good

Free text: Oral herpes lesion starting to dry

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-29
Call successful
Completed over the phone
2021-01-01
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-08
Dose 2 — Pfizer-BioNTech
2021-01-16
Survey response — day 7, dose 2
MedDRA: Arthralgia, Back pain, Chills, Cough, Dizziness, Flushing, Headache, Musculoskeletal chest pain, Nausea, Night sweats, Productive cough — Feeling: Good · Be unable to work, Be unable to do your normal daily activities

Free text: Mild residual cough today. For 3 days post second vaccine: Chills Lightheaded Nauseous Flush Headache Nights sweats Sat night Joint pain-hips and back Left sided rib pain-felt like shingles without rash Moist cough (> 3 weeks, worse after 2nd shot)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-16
Report sent to call center — day 7, dose 2
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-01-23
Survey response — day 14, dose 2
MedDRA: Cough, Musculoskeletal chest pain, Oral herpes — Feeling: Good

Free text: On 1/17/21 I developed a second oral herpes lesion, rib pain (shingles-like), increased cough. I restarted acyclovir; improved in 2 days. At present, 1/23 minor intermittent cough. No other symptoms.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-30
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-05
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-02-14
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-02-19
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-09
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-09
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-01-08
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-18	Pfizer-BioNTech
2	2021-01-08	Pfizer-BioNTech

Call center

2 call center cases

1 successful · 1 priority 2/3 (triaged and no follow up)

VAERS report filed, before or during a call: 1

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 1

2020-12-21

Systemic reaction (other): New morbilliform rash on upper extremities, chest and abdomen. Mild shortness of breath when running

2020-12-22

Systemic reaction (other): Morbilliform rash upper arms, chest and abdomen improved; new mild cough and intermittent breathlessness; new oral herpes lesion (first time in over a year and most severe in a decade

Healthcare visit (other): Went to Covid screening area based on occupational health recommendation due to new respiratory symptoms. Covid test negative.

2020-12-23

Systemic reaction (other): Still occasionally breathless and with occasional cough

Release 1 — day 7, dose 1

2020-12-25

Systemic reaction (other): Oral herpes lesion starting to dry

Release 2 — day 7, dose 2

2021-01-16

Systemic reaction (other): Mild residual cough today. For 3 days post second vaccine: Chills Lightheaded Nauseous Flush Headache Nights sweats Sat night Joint pain-hips and back Left sided rib pain-felt like shingles without rash Moist cough (> 3 weeks, worse after 2nd shot)

Release 2 — day 14, dose 2

2021-01-23

Symptoms: On 1/17/21 I developed a second oral herpes lesion, rib pain (shingles-like), increased cough. I restarted acyclovir; improved in 2 days. At present, 1/23 minor intermittent cough. No other symptoms.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Office visit	✓	✓	✓
HCVO	Respiratory symptom	✓	✓	✓
HCVO	SARS-CoV-2 test negative	✓	✓	✓
SD	Cough	✓	✓	✓
SD	Musculoskeletal chest pain	✓	✓	✓
SD	Oral herpes	✓	✓	✓
SRO	Arthralgia	✓	✓	✓
SRO	Back pain	✓	✓	✓
SRO	Chills	✓	✓	✓
SRO	Condition aggravated	○	○	○
SRO	Cough	✓	✓	✓
SRO	Dizziness	✓	✓	✓
SRO	Dyspnoea	✓	✓	✓
SRO	Dyspnoea exertional	✓	✓	✓
SRO	Flushing	✓	✓	✓
SRO	Headache	✓	✓	✓
SRO	Herpes simplex	✓	✓	✓
SRO	Musculoskeletal chest pain	✓	✓	✓
SRO	Nausea	✓	✓	✓
SRO	Night sweats	✓	✓	✓
SRO	Oral herpes	✓	✓	✓
SRO	Productive cough	✓	✓	✓
SRO	Rash	✓	✓	✓
SRO	Rash morbilliform	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release